Farnesoid X Receptor, through the binding wíth Steroidogenic Fuctor I Responsive Element, inhibits uromutase expression in tumor Leydig cells.
dc.contributor.author | Malivindi,Rocco | |
dc.contributor.author | Sisci,Diego | |
dc.contributor.author | Andò,Sebastiano | |
dc.date.accessioned | 2013-10-21T09:43:40Z | |
dc.date.available | 2013-10-21T09:43:40Z | |
dc.date.issued | 2013-10-21 | |
dc.description | Dottoruto di Ricerca in: Biochimica CellulAre ed Attività dei Farmaci in Oncologia, XXII Ciclo, a.a.2008-2009 Campo di Ricerca MED/04-PATOLOGIA GENERALE XXII Ciclo | en_US |
dc.description.sponsorship | Università della Calabria | en_US |
dc.identifier.uri | http://hdl.handle.net/10955/307 | |
dc.language.iso | en | en_US |
dc.relation.ispartofseries | MED/04; | |
dc.subject | Biochimica Cellulare | en_US |
dc.subject | Tumore a cellule di Leydig | en_US |
dc.title | Farnesoid X Receptor, through the binding wíth Steroidogenic Fuctor I Responsive Element, inhibits uromutase expression in tumor Leydig cells. | en_US |
dc.type | Thesis | en_US |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Tesi Dottorato Dr Rocco Malivindi.pdf
- Size:
- 4.57 MB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: